About
We are creating new approach to treat currently incurable respiratory diseases. Our pipeline of advanced therapies intersect regenerative medicine and gene therapy in the hope of treating these devastating lung diseases of severely unmet patient need. Our platform technology is based on inhaled bioengineered stem cell exosomes which are capable of efficient intracellular delivery of a variety of therapeutic cargoes to effectively treat diseases including CF and lung cancer.
Katie Gilligan
Head of R&DR&D 0874110714
kgilligan@omnispirant.com
Website
View WebsiteAddress
Stradbally East, Kilcolgan, Galway,
Galway,
H91 D29F,
Ireland
kgilligan@omnispirant.com
Areas of Expertise
- Cell therapy (Allogeneic)
- Clinical
- Delivery
- Gene Therapy (non-viral)
- Manufacturing sciences
- Process Development
- RNA